Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

Leukemia. 2020 Feb;34(2):635-639. doi: 10.1038/s41375-019-0586-6. Epub 2019 Oct 4.

Anna B Halpern^{1

2}, Nicholas P Howard², Megan Othus³, Paul C Hendrie¹, Nikita V Baclig⁴, Sarah A Buckley², Mary-Elizabeth M Percival^{1

2}, Pamela S Becker^{1

2}, Bart L Scott^{2

5}, Vivian G Oehler^{1

2}, Terry B Gernsheimer^{1

2}, Siobán B Keel¹, Johnnie J Orozco^{2

5}, Ryan D Cassaday^{1

2}, Andrei R Shustov^{1

2}, Garrett A Hartley⁶, Verna L Welch⁶, Elihu H Estey^{1

2}, Roland B Walter^{7

8

9

10}

¹ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁴ Department of Medicine, Residency Program, University of Washington, Seattle, WA, USA.
⁵ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
⁶ Pfizer Inc., New York, NY, USA.
⁷ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.
⁸ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rwalter@fredhutch.org.
⁹ Department of Pathology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.
¹⁰ Department of Epidemiology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.

No abstract available

Publication types